Fecal S100A12 levels measured by a new ELISA are increased in ulcerative colitis (UC) and Crohn’s disease (CD) and correlates with intestinal damage

Fecal S100A12 levels measured by a new ELISA are increased in ulcerative colitis (UC) and Crohn’s disease (CD) and correlates with intestinal damage

Bibliographic Details
Main Authors:	Vermeire S, Préaudat C, Garnero P
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Journal of Translational Medicine

Similar Items

Prevalence of intestinal protozoan infection in patients with ulcerative colitis (UC) in Isfahan, Iran
by: Nader Pestechian, et al.
Published: (2021-01-01)

Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.
by: Edgar S Wills, et al.
Published: (2014-01-01)

Ulcerative colitis or Crohn’s disease?
by: R. G. Artamonov, et al.
Published: (2016-03-01)

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
by: Maria Dobre, et al.
Published: (2018-01-01)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
by: Brian M. Yan, et al.
Published: (2021-06-01)

Age peculiarities of intestinal microbiocenosis disorders in the patients with ulcerative colitis and Crohn’s disease
by: Yu.M. Stepanov, et al.
Published: (2020-10-01)

Fecal microbiota transplantation for ulcerative colitis
by: Katsuyoshi Matsuoka
Published: (2021-01-01)

Fecal leukocyte in the diagnosis of ulcerative colitis
by: Takeshi Saraya, et al.
Published: (2014-03-01)

Review of pregnancy in Crohn’s disease and ulcerative colitis
by: Robyn Laube, et al.
Published: (2021-05-01)

Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
by: A. E. Dorofeyev, et al.
Published: (2013-01-01)

Immunological studies in ulcerative colitis and crohn's disease
by: Jewell, D. P.
Published: (1972)

Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
by: Amani S. Awaad, et al.
Published: (2017-12-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

CLINICOPATHOLOGIC PECULIARITIES OF NONSPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE
by: S. D. Strelkova, et al.
Published: (2021-07-01)

Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
by: N A Danilova, et al.
Published: (2019-04-01)

BODY COMPOSITION IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
by: Ivi Ribeiro BACK, et al.
Published: (2017-03-01)

Expressing the differences between Crohn disease and ulcerative colitis.
Published: (2005-08-01)

Two for One: Coexisting Ulcerative Colitis and Crohn’s Disease
by: Grant I Chen, et al.
Published: (2002-01-01)

Expressing the differences between Crohn disease and ulcerative colitis.
by: Cisca Wijmenga
Published: (2005-08-01)

Why Distinguish between Ulcerative Colitis and Crohn’s Disease?
by: Daniel Rachmilewitz
Published: (1989-01-01)

Quality of Life and Coping with Ulcerative colitis and Crohn's disease
by: Larsson, Kjerstin
Published: (2007)

The employment experiences of ulcerative colitis and Crohn's disease sufferers
by: Robson, K. F.
Published: (1999)

Monocyte and T cell plasticity in Crohn’s disease and ulcerative colitis
by: Bsat, Marwa
Published: (2021)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01)

The comparative efficacy of biologics in patients with Crohn´s disease and Ulcerative Colitis
by: Khalaf, Elan Adel
Published: (2019)

Salivary Stress/Immunological Markers in Crohn’s Disease and Ulcerative Colitis
by: Alberto Finamore, et al.
Published: (2020-11-01)

Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
by: Jagadesan Sankarasubramanian, et al.
Published: (2020-11-01)

Risk Factors for Relapse and Recurrence of Ulcerative Colitis and Crohn’s Disease
by: Paul Rutgeerts
Published: (1993-01-01)

Smart Model to Distinguish Crohn’s Disease from Ulcerative Colitis
by: Anna Kasperczuk, et al.
Published: (2019-04-01)

ULCERATIVE COLITIS AND CROHN DISEASE IN CHILDREN – AN EVOLVING PROBLEM IN ROMANIA
by: Cristina Becheanu, et al.
Published: (2014-06-01)

A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
by: Alana Persaud, et al.
Published: (2019-12-01)

The rectal mucosal but not fecal microbiota detects subclinical ulcerative colitis
by: Yu-Fei Lin, et al.
Published: (2021-01-01)

Incidental benefits after fecal microbiota transplant for ulcerative colitis
by: Ramit Mahajan, et al.
Published: (2020-07-01)

Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
by: Akihito Sakuraba, et al.
Published: (2021-05-01)

Intestinal Giardiasis Disguised as Ulcerative Colitis
by: Yu Zhen, et al.
Published: (2018-01-01)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
by: Alexandre Jentzer, et al.
Published: (2020-07-01)

MEDICAL NUTRITION FOR NON SPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE IN CHILDREN
by: O.A. Tutina, et al.
Published: (2008-09-01)

The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis
by: Neal Shahidi, et al.
Published: (2016-05-01)

Comparative Clinical and Paraclinical Analysis of Ulcerative Colitis and Crohn’s Disease in Children
by: M.F. Denysova, et al.
Published: (2016-03-01)